Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

被引：0

作者：

Jennifer Landsberg

Judith Kohlmeyer

Marcel Renn

Tobias Bald

Meri Rogava

Mira Cron

Martina Fatho

Volker Lennerz

Thomas Wölfel

Michael Hölzel

Thomas Tüting

机构：

[1] Laboratory of Experimental Dermatology,Department of Dermatology and Allergy

[2] University of Bonn,Third Department of Medicine

[3] D-53105 Bonn,Department of Clinical Chemistry and Clinical Pharmacology

[4] Germany,undefined

[5] Haematology/Oncology/Pneumology,undefined

[6] University Medical Centre of the Johannes Gutenberg University,undefined

[7] D-55101 Mainz,undefined

[8] Germany,undefined

[9] Unit for RNA Biology,undefined

[10] University of Bonn,undefined

[11] D-53105 Bonn,undefined

[12] Germany,undefined

来源：

Nature | 2012年 / 490卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

A genetically engineered mouse model is used to determine the mechanism of acquired resistance to adoptive therapy with cytotoxic T cells specific for a melanocytic differentiation antigen; tumour necrosis factor (TNF)-α is identified as a crucial factor that causes reversible dedifferentiation of mouse and human melanoma cells.

引用

页码：412 / 416

页数：4

共 50 条

[31] Inflammation-induced foam cell formation in chronic inflammatory disease
Angelovich, Thomas A.
Hearps, Anna C.
Jaworowski, Anthony
IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (08): : 683 - 693
[32] T-Cell Cancer after CAR T-Cell Therapy
Mitchell, Emily
Vassiliou, George S.
NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2120 - 2121
[33] Heterogeneity of T-cell clones infiltrating primary malignant melanomas
Yazdi, Amir S.
Morstedt, Kathrin
Puchta, Ursula
Ghoreschi, Kamran
Flaig, Michael J.
Rocken, Martin
Sander, Christian A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (02) : 393 - 398
[34] Selectins, T-cell rolling and inflammation
Rossiter, H
Alon, R
Kupper, TS
MOLECULAR MEDICINE TODAY, 1997, 3 (05): : 214 - 222
[35] T-cell oligoclonality in CNS inflammation
Olivito, B
Biagioli, T
Aldinucci, A
Ballerini, C
Massacesi, L
JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 225 - 225
[36] T-cell trafficking into sites of inflammation
Hamann, A
Syrbe, U
RHEUMATOLOGY, 2000, 39 (07) : 696 - 699
[37] M2-polarized macrophages as a potential cell therapy to mitigate inflammation-induced preterm birth
Garcia-Flores, Valeria
Romero, Roberto
Xu, Yi
Miller, Derek
Slutsky, Rebecca
Robertson, Sarah A.
Gomez-Lopez, Nardhy
JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
[38] Efalizumab, a reversible T-cell modulator for psoriasis
Shear, NH
Langley, RG
Ho, V
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2005, 9 : 4 - 9
[39] CHYLOTHORAX CAUSING REVERSIBLE T-CELL DEPLETION
BREAUX, JR
MARKS, C
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1988, 28 (05): : 705 - 707
[40] TGFβ Receptor Signaling Is Essential for Inflammation-Induced but Not β-Cell Workload-Induced β-Cell Proliferation
Xiao, Xiangwei
Wiersch, John
El-Gohary, Yousef
Guo, Ping
Prasadan, Krishna
Paredes, Jose
Welsh, Carey
Shiota, Chiyo
Gittes, George K.
DIABETES, 2013, 62 (04) : 1217 - 1226

← 1 2 3 4 5 →